4ZFO | J22.9-xi: chimeric mouse/human antibody against human BCMA (CD269) | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Marino, S.F., Daumke, O., Olal, D. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.90 | ||||||||||||
ligand | BTB, CU | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma., Oden F, Marino SF, Brand J, Scheu S, Kriegel C, Olal D, Takvorian A, Westermann J, Yilmaz B, Hinz M, Daumke O, Hopken UE, Muller G, Lipp M, Mol Oncol. 2015 Mar 31. pii: S1574-7891(15)00068-X. doi:, 10.1016/j.molonc.2015.03.010. PMID:25953704 |
Data retrieval |
View 4ZFO in 3D |
Visual 3D analysis of 4ZFO |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4ZFO |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |